Peroxisome proliferator-activated receptor agonists with phenethylphenylphthalimide skeleton derived from thalidomide-related liver X receptor antagonists: …
K Motoshima, M Ishikawa, Y Hashimoto…
Index: Motoshima, Kazunori; Ishikawa, Minoru; Hashimoto, Yuichi; Sugita, Kazuyuki Bioorganic and Medicinal Chemistry, 2011 , vol. 19, # 10 p. 3156 - 3172
Full Text: HTML
Citation Number: 7
Abstract
Abstract Introduction of an alkylcarboxylic acid unit, which is a partial structure of endogenous peroxisome proliferator-activated receptor (PPAR) ligands, into a phenethylphenylphthalimide skeleton, which possesses liver X receptor (LXR) antagonistic activity, afforded novel PPAR ligands. The results of structure–activity relationship analysis and docking studies led us to the potent PPAR agonists 13c–e. The absolute configuration ...
Related Articles:
[Koz'minykh, V. O.; Shavkunova, G. A.; Berezina, E. S.; Igidov, N. M.; Koz'minykh, E. N.; et al. Pharmaceutical Chemistry Journal, 1994 , vol. 28, # 12 p. 906 - 911 Khimiko-Farmatsevticheskii Zhurnal, 1994 , vol. 28, # 12 p. 32 - 35]
[Yang, Mingdi; Xu, Dongling; Xi, Wengang; Wang, Lianke; Zheng, Jun; Huang, Jing; Zhang, Jingyan; Zhou, Hongping; Wu, Jieying; Tian, Yupeng Journal of Organic Chemistry, 2013 , vol. 78, # 20 p. 10344 - 10359]
[Weichert; Longino; Schwendner; Counsell Journal of Medicinal Chemistry, 1986 , vol. 29, # 9 p. 1674 - 1682]
[Hebbar, Nordine; Ramondenc, Yvan; Ple, Gerard; Dupas, Georges; Ple, Nelly Tetrahedron, 2009 , vol. 65, # 21 p. 4190 - 4200]